MMJ Recs

DECEMBER 17, 2023

The Texas Compassionate Use Program (TCUP) represents the Lone Star State’s cautious foray into the realm of medical marijuana. Enacted in 2015, the program was designed to provide a narrow avenue for patients suffering from qualifying conditions to access low-THC cannabis under the supervision of qualified healthcare professionals.

Law 52

Law Dispensary Clinical Trials Programs 52

Cannabis Law Report

MARCH 1, 2022

Work with the Lead of Regulatory Affairs and the atai Development Team, and with moderate/minimal supervision, with select project teams within subsidiary organizations to develop and oversee program specific regulatory, clinical and development strategies. Represent the company as the Regulatory Affairs expert before U.S.

Clinical Trials 52

Clinical Trials Environment Pharmaceutical Programs 52

Cannabis Law Report

OCTOBER 2, 2021

Work with the Lead of Regulatory Affairs and the atai Development Team, and with moderate/minimal supervision, with select project teams within subsidiary organizations to develop and oversee program specific regulatory, clinical and development strategies. Represent the company as the Regulatory Affairs expert before U.S.

Clinical Trials 52

Clinical Trials Environment Pharmaceutical Programs 52

Cannabis Law Report

FEBRUARY 10, 2022

Despite Petitioners’ noble cause, the case turned on a technicality after the Court determined that the DEA’s letter stating that such psilocybin treatment was not allowed, the document that prompted the lawsuit, was not a “final” decision of the Attorney General that the Court had jurisdiction to review. Background. Psilocybin. The RTT Act.

DEA 52

DEA Clinical Trials Policy Research and Development 52

Puff Puff Post

OCTOBER 3, 2019

Leading the pilot research project is Dr. Eric Hollander, director of the Autism and Spectrum Program and Anxiety and Depression Program at Montefiore Hospital. Alexander Kolevzon, clinical director of the Seaver Autism Center at Mount Sinai, is skeptical due to the wide range of symptoms that are present on the autism spectrum.

Research and Development 94

Research and Development Epilepsy Clinical Trials Treatment 94

Cannabis Law Report

AUGUST 25, 2021

“Lucid has successfully developed a strong pipeline of novel therapeutic compounds — supported by IP in order to advance to future clinical trials — and we are confident that the experience the Lucid leadership team brings will allow us to immediately start the process towards clinical trials to further advance these promising therapies.

Clinical Trials 111

Clinical Trials Research and Development Therapy Conditions 111

MedicalJane

JUNE 29, 2018

Use of CBD in seizure prevention is well-documented with research ; and now, after conducting its own trials, the FDA appears to agree. Epidiolex’s effectiveness was studied in three randomized, double-blind, placebo-controlled clinical trials involving 516 patients with either Lennox-Gastaut syndrome or Dravet syndrome.

Clinical Trials 53

Clinical Trials CBD DEA Research and Development 53

Puff Puff Post

OCTOBER 3, 2019

Leading the pilot research project is Dr. Eric Hollander, director of the Autism and Spectrum Program and Anxiety and Depression Program at Montefiore Hospital. Alexander Kolevzon, clinical director of the Seaver Autism Center at Mount Sinai, is skeptical due to the wide range of symptoms that are present on the autism spectrum.

Research and Development 40

Research and Development Epilepsy Clinical Trials Treatment 40

The Cannigma

JULY 1, 2022

However, a result can be statistically significant but not clinically significant–meaning that even though a study may detect a difference on paper, it may make no tangible difference in real-world application. Non-clinical research can help answer questions regarding safety and risk in very powerful ways.

Research and Development 108

Research and Development Data THC Clinical Trials 108

Cannabis Law Report

JANUARY 20, 2022

ELE-Psilo program expected to enter clinical trials in Q2 2022 and to target the pressing need for rapid-acting antidepressants compatible with existing healthcare infrastructure and insurance. This document relates to a proposed transaction between Eleusis and Silver Spike. Forward-Looking Statements.

Therapy 52

Therapy Research and Development Business Access 52

TheAnswerPage

JANUARY 11, 2022

According to state laws, in order to purchase medical marijuana products, a patient must first obtain a recommendation (not a prescription) for medical marijuana from a clinician and enroll in the state medical marijuana program.

Patients 98

Patients Education Marijuana Therapy 98

Cannabis Law Report

DECEMBER 7, 2021

Since 2017, several clinical trials and observational studies have examined the efficacy of MCs in the pediatric population for a few indications, most of them focused on CBD efficacy in Dravet syndrome 28 , 29 , 30. A reason for exclusion for every individual study was documented. Disagreements were resolved by discussion.

Safety 52

Safety Cannabinoids Events Data 52

Cannabis Law Report

JULY 25, 2022

Reporter Elise Worthington also investigates the dark side of this form of therapy where disturbing cases of abuse and malpractice are emerging in both clinical trials and the underground. Clinically, Eli is interested in the deep connections between trauma and addiction and works within a neuro-psychoanalytic framework.

Medicine 52

Medicine Therapy Research and Development Business 52

Cannabis Law Report

JULY 28, 2021

However, prior to committing to a substantial clinical program for that indication, PharmaDrug looked to further expand on the body of existing supportive data for esophageal cancer, while also potentially revealing new, promising cancer indications. ” Next Steps. Cepharanthine’s Rationale in Cancer.

Research and Development 105

Research and Development Clinical Trials Treatment Pharmaceutical 105

Cannabis Law Report

JUNE 11, 2019

While there is anecdotal evidence that CBD does have beneficial properties, I heard no evidence that that claim has been established through recognized clinical trials. The medical cannabis program recommended was “medically justified” but evidence as to costs and recommended length of the program was lacking.

Chronic Pain 45

Chronic Pain Cannabis History Treatment 45

WeedAdvisor

AUGUST 3, 2019

This means approving the medical cannabis products before clinical trials are complete – a move that does not bode well with some government officials and health organizations. As the fate of Brazil’s medical cannabis program remains unknown, WeedAdvisor intends to raise awareness among our South American partners.

Clinical Trials 51

Clinical Trials Cultivation Legislation Cannabis 51

The Cannigma

FEBRUARY 1, 2023

Unlike healthy cells, these abnormal cells don’t die as they are typically programmed to do, and instead begin to grow and divide uncontrollably, effectively circumventing the body’s normal checks and balances. To date, very few human clinical trials have been conducted to assess the effectiveness of THC or CBD in treating cancer.

Clinical Trials 145

Clinical Trials Research and Development Therapy Cannabinoids 145

The Cannigma

MARCH 12, 2021

We’re not going to get over the fact that there’s not the same sort of clinical trial and that type of evidence for cannabis and cannabis treatments in the very near future for various reasons. But what happens to the medical programs and access and probably in ways that I don’t even know what to ask?

Legalization 128

Legalization Patients Education Dispensary 128

Weedistry

FEBRUARY 4, 2019

Currently, 33 states along with the District of Columbia, Guam and Puerto Rico have passed laws for comprehensive medical cannabis programs — but critics often point out we’re lacking definitive proof that marijuana safely and effectively treats many of the qualifying conditions. There are two things wrong with this argument.

Clinical Trials 40

Clinical Trials Pharmaceutical Chronic Pain Safety 40

Cannabis Law Report

JUNE 4, 2021

Rick, and MAPS, have published hundreds of research papers, articles, and reports over the past several decades in addition to participation in dozens of clinical trials and international studies. David joined the faculty at UC Davis in 2015, where he established a research program at the interface of chemistry and neuroscience.

Research and Development 51

Research and Development Medicine Treatment Pharmaceutical 51

SpeedWeed

DECEMBER 28, 2018

As first reported by Leafly, Altria has “over the past five years quietly patented dozens of devices that could be used to consume marijuana, a review of public documents at the US Patent and Trademark Office shows.” Buzz: Cannabis Equity Programs Expand Opportunities. The shop’s proprietor, Alphonso T Blunt, Jr.,

Pharmaceutical 40

Pharmaceutical Research and Development Legalization CBD 40

NORML

SEPTEMBER 20, 2019

Essentially, the federal government has monopolized cannabis research, and ElSohly’s product, according to some scientists who’ve seen it, is unsuitable for clinical trials. It’s been nearly three years since the DEA announced its revolutionary cultivator program. That’s what made it unlawful.

DEA 227

DEA Research and Development Clinical Trials Patients 227

NORML

JANUARY 28, 2019

The National Center for Biotechnology Information has summarized a group of FDA approved randomized clinical trials, finding evidence for cannabis as medicine. A 2016 study published in the Journal of School Health concluded alcohol use should be a target of school abuse prevention programs.

Data 188

Data Clinical Trials Chronic Pain Medicine 188

Cannabis Law Report

JUNE 30, 2019

New Mexico expands medical cannabis program to include protections against discrimination, reciprocity with other states’ medical programs, and three-year renewal cycle (up from one) for medial cannabis cards; and. Congress has asked vaporizer company JUUL for documents on any partnerships it may have with cannabis companies.

Chronic Pain 40

Chronic Pain Legislation Treatment Programs 40

Cannabis Law Report

DECEMBER 30, 2019

Illinois and the US territory of Guam legalized adult-use cannabis and its retail sale, medical cannabis programs were enacted and expanded in several states, and 27 states considered legislation that would have legalized adult-use cannabis, a record-high. Continued Protections for State Legal Medical Programs. California.

Legislation 59

Legislation Patients Access Banking 59